| Joel Vincent Kaluzny, MD | |
|
135 S Sharon Amity Rd Ste 100, Charlotte, NC 28211-3870 | |
| (704) 365-0555 | |
| Not Available |
| Full Name | Joel Vincent Kaluzny |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 7 Years |
| Location | 135 S Sharon Amity Rd Ste 100, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407248180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2021-02133 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Horizon Eye Care Pa | 2163484072 | 25 |
| Horizon Eye Care Pa | 2163484072 | 25 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression.
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
This substantially enhanced second-generation module of the FoodScreener™ for wine profiling allows easy and cost-efficient NMR-based wine analysis, now for the first time also for key regions in France, Italy and Spain. In addition to geographical origin, NMR Wine Profiling can determine further key authenticity parameters such as grape variety, vintage year and possible water addition. This comprehensive solution offers a quick, fully automated and cost-efficient tool to ensure wine quality and authenticity, protecting brand integrity and consumer confidence.
Alliance HealthCare Services, Inc., announced today that it has received tenders and consents on or prior to 5:00 p.m., New York City time on November 25, 2009 (the "Consent Date") representing approximately 98.1% of the $300 million aggregate principal amount of its outstanding 7¼% Senior Subordinated Notes due 2012 (the "notes").
› Verified 7 days ago
| Entity Name | Horizon Eye Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235192113 PECOS PAC ID: 2163484072 Enrollment ID: O20041102001221 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression.
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
This substantially enhanced second-generation module of the FoodScreener™ for wine profiling allows easy and cost-efficient NMR-based wine analysis, now for the first time also for key regions in France, Italy and Spain. In addition to geographical origin, NMR Wine Profiling can determine further key authenticity parameters such as grape variety, vintage year and possible water addition. This comprehensive solution offers a quick, fully automated and cost-efficient tool to ensure wine quality and authenticity, protecting brand integrity and consumer confidence.
Alliance HealthCare Services, Inc., announced today that it has received tenders and consents on or prior to 5:00 p.m., New York City time on November 25, 2009 (the "Consent Date") representing approximately 98.1% of the $300 million aggregate principal amount of its outstanding 7¼% Senior Subordinated Notes due 2012 (the "notes").
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Vincent Kaluzny, MD Po Box 60160, Charlotte, NC 28260-0160 Ph: (704) 365-0555 | Joel Vincent Kaluzny, MD 135 S Sharon Amity Rd Ste 100, Charlotte, NC 28211-3870 Ph: (704) 365-0555 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression.
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
This substantially enhanced second-generation module of the FoodScreener™ for wine profiling allows easy and cost-efficient NMR-based wine analysis, now for the first time also for key regions in France, Italy and Spain. In addition to geographical origin, NMR Wine Profiling can determine further key authenticity parameters such as grape variety, vintage year and possible water addition. This comprehensive solution offers a quick, fully automated and cost-efficient tool to ensure wine quality and authenticity, protecting brand integrity and consumer confidence.
Alliance HealthCare Services, Inc., announced today that it has received tenders and consents on or prior to 5:00 p.m., New York City time on November 25, 2009 (the "Consent Date") representing approximately 98.1% of the $300 million aggregate principal amount of its outstanding 7¼% Senior Subordinated Notes due 2012 (the "notes").
› Verified 7 days ago
Dr. Lisa Anne Collea, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3468 | |
Ernest M. Bhend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3121 | |
Dr. James Wesley Heroman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 497 N Wendover Rd, Charlotte, NC 28211 Phone: 704-376-5424 Fax: 704-376-5354 | |
Dr. Benjamin Charles Kramer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 135 S Sharon Amity Rd Ste 100, Charlotte, NC 28211 Phone: 704-365-0555 Fax: 704-367-8120 | |
Jeffrey Ryan Stetler, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6035 Fairview Rd, Charlotte, NC 28210 Phone: 704-295-3000 Fax: 704-295-3468 | |
Dr. Samuel Santander, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3621 Randolph Road, Suite 100, Charlotte, NC 28211 Phone: 704-332-9365 Fax: 704-364-7384 | |
Dr. Judy Diane Hustead, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 135 S Sharon Amity Rd, Suite 100, Charlotte, NC 28211 Phone: 704-365-0555 Fax: 704-367-8124 |